{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:13:34Z","timestamp":1790342014571,"version":"4.1.0"},"reference-count":37,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Relapse continues to place significant burden on patients and tuberculosis (TB) programmes worldwide. We aimed to determine clinical and microbiological factors associated with relapse in patients treated with the WHO standard 6-month regimen and then evaluate the accuracy of each factor at predicting an outcome of relapse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic review was performed to identify randomised controlled trials reporting treatment outcomes on patients receiving the standard regimen. Authors were contacted and invited to share patient-level data (IPD). A one-step IPD meta-analysis, using random intercept logistic regression models and receiver operating characteristic curves, was performed to evaluate the predictive performance of variables of interest.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Individual patient data were obtained from 3 of the 12 identified studies. Of the 1189 patients with confirmed pulmonary TB who completed therapy, 67 (5.6%) relapsed. In multipredictor analysis, the presence of baseline cavitary disease with positive smear at 2\u2009months was associated with an increased odds of relapse (OR 2.3(95% CI 1.3 to 4.2)) and a relapse risk of 10%. When area under the curve for each multipredictor model was compared, discrimination between low-risk and higher-risk patients was modest and similar to that of the reference model which accounted for age, sex and HIV status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Despite its poor predictive value, our results indicate that the combined presence of cavitary disease and 2-month positive smear status may be the best currently available marker for identifying individuals at an increased risk of relapse, particularly in resource-limited setting. Further investigation is required to assess whether this combined factor can be used to indicate different treatment requirements in clinical practice.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2017-211120","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T17:19:24Z","timestamp":1542043164000},"page":"291-297","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis"],"prefix":"10.1136","volume":"74","author":[{"given":"Kamila","family":"Romanowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F","family":"Balshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon R","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Ahmad Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"2020050723472343000_74.3.291.1","unstructured":"WHO. Treatment of Tuberculosis Guidelines. 4th Edition: WHO, 2010. http:\/\/www.who.int\/tb\/publications\/2010\/9789241547833\/en\/. (accessed 7 Jun 2016)."},{"key":"2020050723472343000_74.3.291.2","unstructured":"WHO. Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update). WHO 2017 http:\/\/www.who.int\/tb\/publications\/2017\/dstb_guidance_2017\/en\/ (accessed 24 May 2017)."},{"key":"2020050723472343000_74.3.291.3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000146"},{"key":"2020050723472343000_74.3.291.4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5588\/ijtld.15.0224","article-title":"Reducing relapse in tuberculosis treatment: is it time to reassess WHO treatment guidelines?","volume":"19","author":"Johnston","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020050723472343000_74.3.291.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06712-5"},{"key":"2020050723472343000_74.3.291.6","first-page":"556","article-title":"Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India","volume":"9","author":"Thomas","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020050723472343000_74.3.291.7","unstructured":"WHO. Global tuberculosis report 2016. 2016 http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ (accessed 13 Oct 2016)."},{"key":"2020050723472343000_74.3.291.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09742-8"},{"key":"2020050723472343000_74.3.291.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.01.010"},{"key":"2020050723472343000_74.3.291.10","doi-asserted-by":"crossref","unstructured":"Nahid P , Dorman SE , Alipanah N , et al . Official american thoracic society\/centers for disease control and prevention\/infectious diseases society of america clinical practice guidelines: Treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016:ciw376.","DOI":"10.1093\/cid\/ciw566"},{"key":"2020050723472343000_74.3.291.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70071-2"},{"key":"2020050723472343000_74.3.291.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407426"},{"key":"2020050723472343000_74.3.291.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314210"},{"key":"2020050723472343000_74.3.291.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315817"},{"key":"2020050723472343000_74.3.291.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013911"},{"key":"2020050723472343000_74.3.291.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.436"},{"key":"2020050723472343000_74.3.291.17","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70733-9"},{"key":"2020050723472343000_74.3.291.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200903-0439OC"},{"key":"2020050723472343000_74.3.291.19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200904-0536OC"},{"key":"2020050723472343000_74.3.291.20","unstructured":"New tb clinical trial data-sharing platform available for researchers | critical path institute. https:\/\/c-path.org\/tb-pacts-launch\/ (accessed 24 May 2017)."},{"key":"2020050723472343000_74.3.291.21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/cid\/cix121","article-title":"Effect of intermittency on treatment outcomes in pulmonary tuberculosis: An updated systematic review and metaanalysis","volume":"64","author":"Johnston","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020050723472343000_74.3.291.22","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L"},{"key":"2020050723472343000_74.3.291.23","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"2020050723472343000_74.3.291.24","unstructured":"RStudio Team. RStudio: Integrated Development for R. Boston, MA: RStudio,Inc, 2016. http:\/\/www.rstudio.com\/."},{"key":"2020050723472343000_74.3.291.25","unstructured":"Bates D , M\u00e4chler M , Bolker B , et al . Fitting linear mixed-effects models using lme4. 2014. ArXiv Prepr ArXiv14065823 Published Online First https:\/\/arxiv.org\/abs\/1406.5823 (accessed 14 Jun 2017)."},{"key":"2020050723472343000_74.3.291.26","doi-asserted-by":"crossref","unstructured":"Robin X , Turck N , Hainard A , et al . pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77.doi:10.1186\/1471-2105-12-77","DOI":"10.1186\/1471-2105-12-77"},{"key":"2020050723472343000_74.3.291.27","unstructured":"Harrell F , Harrell FE Jr . rms: Regression Modeling Strategies. R package version 5.1-0. 2017 https:\/\/CRAN.R-project.org\/package=rms."},{"key":"2020050723472343000_74.3.291.28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.3656"},{"key":"2020050723472343000_74.3.291.29","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0565-y"},{"key":"2020050723472343000_74.3.291.30","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01064-2015"},{"key":"2020050723472343000_74.3.291.31","doi-asserted-by":"crossref","first-page":"431.e1","DOI":"10.1016\/j.jclinepi.2006.09.009","article-title":"Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods","volume":"60","author":"Riley","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"2020050723472343000_74.3.291.32","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-81"},{"key":"2020050723472343000_74.3.291.33","doi-asserted-by":"crossref","unstructured":"Lee PH , Lin HC , Huang AS , et al . Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PLoS One 2014;9:e92623.doi:10.1371\/journal.pone.0092623","DOI":"10.1371\/journal.pone.0092623"},{"key":"2020050723472343000_74.3.291.34","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00114214"},{"key":"2020050723472343000_74.3.291.35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200511-1834OC"},{"key":"2020050723472343000_74.3.291.36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu574"},{"key":"2020050723472343000_74.3.291.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00414-0"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2017-211120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T06:05:32Z","timestamp":1601100332000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2017-211120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2,14]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/thoraxjnl-2017-211120"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211120","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]}}}